Request Sample

Global Inactivated Vaccine Market

Dec. 1, 2019

Global Inactivated Vaccine Market, By Product Type (Viral, Bacterial), By Inactivation method (Radiation Method, pH Concentration, Heat Inactivation, Solvent Detergent Method, and Others), By Route of Administration (Oral, Subcutaneous, Intravenous, and Others), By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR293      
Industry : Biotechnology
Pages :190 Pages
Format :   PPT Format   PDF Format

The global inactivated vaccine market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020 and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of 3.21% during the forecast period (2020-2025). The global market for inactivated vaccines is estimated to expand at a significant pace during the forecast period. Major factor driving the global market for inactivated vaccines is the increasing demand for inactivated vaccines from government of developing countries. Additionally, the advantages of inactivated vaccines over live attenuated vaccines such as protection, durability and lack of pathogen reactivation chances may be passed on to immunocompromised individuals, thereby supporting the market growth.

Table 1. Global Inactivated Vaccine Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Product Type)

 Viral, Bacterial

Market Segmentation (By Inactivation method)

Radiation Method, pH Concentration, Heat Inactivation, Solvent Detergent Method, and Others

Market Segmentation (By Route of Administration)

Oral, Subcutaneous, Intravenous, and Others

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East & Africa,

Key Players Coverage

Emergent BioSolutions, CSL Limited, Johnson & Johnson, GlaxoSmithKline, Merck Co KGaA, MedImmune, Pfizer, Serum Institute of India Pvt Ltd, Sanofi, among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Inactivated vaccines characteristic such as unable to replicate themselves is expected to drive the market growth. Additionally, the use of inactivated vaccines in polio vaccines is expected to support the market growth. For instance, in 2013, the World Health Organization (WHO) held a strategic programme with aim of strengthening immunization programmes and to introduce at least inactivated poliomyelitis vaccine (IPV), and withdraw oral poliomyelitis vaccine (OPV). Moreover, the rising awareness among individuals regarding immunization and the increase in the prevalence of infectious diseases may drive the market growth. For instance, the sudden coronavirus outbreak, and recent outbreaks such as Ebola, H1N1 had been a significant market contributor for inactivated vaccines.

FIgure 1. PORTER’S Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

North America holds the dominant position in the global market as the favorable government support to healthcare sector is likely to accelerate the growth of inactivated vaccines market in this region. For instance, in May 2020, the Canadian government announced to invest US$ 240 million in online healthcare. As online healthcare is able to track a patient’s history and the number of times he/she may had used vaccines; this, may support the inactivated vaccines market demand. Additionally, in the Asia-Pacific region Bharat Biotech, for instance, launched a JENVAC vaccine in 2013 to provide long-term protection and immunogenicity against Japanese encephalitis. 

Figure 2. Regional Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

The major players in global inactivated vaccine market include Emergent BioSolutions, CSL Limited, Johnson & Johnson, GlaxoSmithKline, Merck Co KGaA, MedImmune, Pfizer, Serum Institute of India Pvt Ltd, Sanofi, among others. The market players are focused on collaborations and research activities to develop new products. For instance, in October 2017, GlaxoSmithKline Plc's Shingrix was approved by the U.S Food and Drug Administration (FDA), a zoster vaccine recombinant adjuvant for shingle protection in adults over 50 years of age. Shingrix is a recombinant, non-live subunit vaccine delivered intramuscularly in two doses.

Figure 3. Market Share of Key Players, 2019

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

By Product Type

  • Viral
  • Bacterial

By Inactivation method

  • Radiation Method,
  • pH Concentration,
  • Heat Inactivation,
  • Solvent Detergent Method
  • Others

By Route of Administration

  • Oral
  • Subcutaneous
  • Intravenous
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides an in-depth analysis of the global inactivated vaccine market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global inactivated vaccine market?
  • What key factors are expected to increase the demand for inactivated vaccine market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global inactivated vaccine market?
  • What is the total market value (US$ Mn) generated in the global inactivated vaccine market by product type in 2019 and what are the forecasts by 2025?
  • Which inactivation method is expected to dominate the inactivated vaccine market in the coming years?
  • Which technology is expected to dominate the inactivated vaccine market in the coming years?
  • What was the total revenue generated by the global inactivated vaccine market across different regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global inactivated vaccine market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the inactivated vaccine market?
  • What are the major outcomes derived from Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have a huge impact on the market?
  • What insights are derived through the analysis of key players on the following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Recombinant DNA Technology Market

Global Recombinant DNA Technology Market, By Product Type (Recombinant Protein Drugs (Insulin, Human Growth Hormone, Erythropoietin, Interferon, Blood Factors, …

Read More

Global Inactivated Vaccine Market

Global Inactivated Vaccine Market, By Product Type (Viral, Bacterial), By Inactivation method (Radiation Method, pH Concentration, Heat Inactivation, Solvent …

Read More

Middle East and Africa Epigenetics Market

Middle East and Africa Epigenetics Market, By Product type (Consumables, Enzymes, Kits & Reagents, and Instruments), By Application (Oncology, …

Read More

Global Tissue Plasminogen Activator (TPA) Market

Global Tissue Plasminogen Activator (TPA) Market, By Dosage (2mg, 50mg, and 100mg), By Administration Route (Intravenous and Regional Intra-Arterial), …

Read More

Global Biobanks Market

Global Biobanks Market, By Biological samples (DNA or RNA, Plasma, Tissue samples, Stem cells, Amniotic fluid, Cerebrospinal fluid, Blood, …

Read More

Global Vector Control Market

Global Vector Control Market, By Product Type (Insects, Rodents, and Others), Methods of control (Chemical Methods (Pyrethroids (Permethrin, Deltamethrin, …

Read More

Global Medical Drone Market

Global Medical Drone Market, By Type (Fixed Wing, Rotary Drone, and Hybrid Drones), By Application (Search and Rescue (Disaster, …

Read More

Global Agricultural Biotechnological Market

Global Agricultural Biotechnological Market, By Product Type (Plants (Conventional Techniques, Established Genetic Modification, New Breeding Techniques), Animals (Conventional Techniques, …

Read More
Validation error occured. Please enter the fields and submit it again.